NPRR.F logo

Nipro OTCPK:NPRR.F Stock Report

Last Price

US$8.23

Market Cap

US$1.4b

7D

0%

1Y

n/a

Updated

12 May, 2025

Data

Company Financials +

Nipro (NPRR.F) Stock Overview

Engages in the medical devices, pharmaceuticals, and pharma packaging businesses. More details

NPRR.F fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance2/6
Financial Health4/6
Dividends3/6

NPRR.F Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Nipro Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for Nipro
Historical stock prices
Current Share PriceJP¥8.23
52 Week HighJP¥8.23
52 Week LowJP¥8.23
Beta0.028
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-45.50%

Recent News & Updates

Recent updates

Shareholder Returns

NPRR.FUS Medical EquipmentUS Market
7D0%-0.2%1.3%
1Yn/a8.2%12.8%

Return vs Industry: Insufficient data to determine how NPRR.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how NPRR.F performed against the US Market.

Price Volatility

Is NPRR.F's price volatile compared to industry and market?
NPRR.F volatility
NPRR.F Average Weekly Movementn/a
Medical Equipment Industry Average Movement9.2%
Market Average Movement7.7%
10% most volatile stocks in US Market17.4%
10% least volatile stocks in US Market4.0%

Stable Share Price: NPRR.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine NPRR.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
194738,117Yoshihiko Sanowww.nipro.co.jp

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical-Related business develops, manufactures, and sells injection and infusion products, artificial organ products, functional products, dialysis products, diabetic products, and pharmaceuticals comprising generic and kit products; and manufactures medical equipment, including dialysis medical device products. This business also operates dialysis and training centers.

Nipro Corporation Fundamentals Summary

How do Nipro's earnings and revenue compare to its market cap?
NPRR.F fundamental statistics
Market capUS$1.44b
Earnings (TTM)US$34.92m
Revenue (TTM)US$4.31b
41.3x
P/E Ratio
0.3x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NPRR.F income statement (TTM)
RevenueJP¥626.93b
Cost of RevenueJP¥441.96b
Gross ProfitJP¥184.97b
Other ExpensesJP¥179.90b
EarningsJP¥5.07b

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

May 20, 2025

Earnings per share (EPS)31.11
Gross Margin29.50%
Net Profit Margin0.81%
Debt/Equity Ratio234.7%

How did NPRR.F perform over the long term?

See historical performance and comparison

Dividends

2.5%
Current Dividend Yield
87%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/12 00:19
End of Day Share Price 2025/02/12 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nipro Corporation is covered by 14 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Masahiro NakanomyoBarclays
Craig NelsonBNP Paribas Securities (Asia)
Yuki YamazakiDaiwa Securities Co. Ltd.